ArticleFrontiers in oncology2025
Aggressive atypical cystic fibromatosis of the pancreas: a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Two rare cases of aggressive fibromatosis originating in the intestinal tract.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aggressive fibromatosis of the pancreas (AFP) is a rare, non-epithelial, aggressive, benign soft tissue tumor of the pancreas that is characterized by β-catenin-positive expression. Due to its rarity, it is often misdiagnosed as a malignant pancreatic tumor. In this report, we present a case of aggressive atypical cystic fibromatosis that is specifically localized to the pancreas. We emphasize the key imaging features essential for diagnosing and assessing the aggressiveness of this condition, along with its pathological characteristics, pathogenesis, and surgical treatment. Progressive delayed enhancement, marked restricted diffusion, and aggressive features can aid in differentiation, and nuclear β-catenin positivity is highly characteristic of this condition. A 22-year-old woman was admitted following the incidental discovery of a cystic-solid pancreatic mass during a routine medical examination. This patient underwent preoperative ultrasound, computed tomography, and magnetic resonance imaging. The identified lesion was subsequently surgically resected, and a histopathological examination confirmed the presence of AFP. Notably, the tumor was found incidentally, as the patient was asymptomatic. Radiologists should consider the possibility of aggressive fibromatosis in patients presenting with pancreatic tumors, as surgical resection can lead to a cure. Therefore, comprehensive imaging analysis is crucial for making an accurate preoperative diagnosis and providing appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.